The science guiding selection of an aerosol delivery device

Respiratory Care

Volumn 58, Issue 11, 2013, Pages 1963-1973

  Myers, Timothy R ^a  

^a American Association for Respiratory Care (AARC)   (United States)

Author keywords

Aerosol therapy; Inhaler; Nebulizer; Respiratory care

Indexed keywords

BRONCHODILATING AGENT; HELIOX;

AEROSOL; AIRFLOW; ARTICLE; ASTHMA; BREATHING MOUTHPIECE; DEVICE SAFETY; DRUG DELIVERY DEVICE; DRUG DISPOSITION; EQUIPMENT DESIGN; HUMAN; JET NEBULIZER; MESH NEBULIZER; NEBULIZATION; NEBULIZER; PARTICLE SIZE; PEAK EXPIRATORY FLOW; ULTRASONIC NEBULIZER;

AEROSOL THERAPY; INHALER; NEBULIZER; RESPIRATORY CARE;

ADMINISTRATION, INHALATION; AEROSOLS; BIOMEDICAL RESEARCH; EQUIPMENT DESIGN; HUMANS; METERED DOSE INHALERS; PRACTICE GUIDELINES AS TOPIC; RESPIRATION DISORDERS;

EID: 84886291154     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.02812     Document Type: Article

References (48)

1. Hess DR. Aerosol delivery devices in the treatment of asthma. Respir Care 2008;53(6):699-723.
2. Gardenhire DS, Hess DR, Myers TR, Rau JL. A guide to aerosol delivery devices for respiratory therapists, 3rd edition. American Association for Respiratory Care; Irving, Texas; 2013.
3. Howarth PH. Why particle size should affect clinical response to inhaled therapy. J Aerosol Med 2001;14(Suppl 1):S27-S34.
4. Amirav I, Newhouse MT. Deposition of small particles in the lung. Paediatr Respir Rev 2012;13(2):73-78.
5. Dolovich MB, Ahrens RC, Hess DR, Anderson P, Dhand R, Rau JL, et al. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest 2005;127(1):335-371.
6. Geller DE. New liquid aerosol generation devices: systems that force pressurized liquids through nozzles. Respir Care 2002;47(12):1392-1404.
7. Dennis JH. A review of issues relating to nebulizer standards. J Aerosol Med 1998;11(Suppl 1):S73-S79.
8. Welch MJ. Nebulization therapy for asthma: a practical guide for the busy pediatrician. Clin Pediatr (Phila) 2008;47(8):744-756.
9. Rau JL, Ari A, Restrepo RD. Performance comparison of nebulizer designs: constant-output, breath-enhanced, and dosimetric. Respir Care 2004;49(2):174-179.
10. Nikander K, Turpeinen M, Wollmer P. The conventional ultrasonic nebulizer proved inefficient in nebulizing a suspension. J Aerosol Med 1999;12(2):47-53.
11. Peters SG. Continuous bronchodilator therapy. Chest 2007;131(1): 286-289.
12. Camargo CA Jr, Spooner CH, Rowe BH. Continuous versus intermittent beta-agonists in the treatment of acute asthma. Cochrane Database Syst Rev 2003;(4):CD001115.
13. Salo D, Tuel M, Lavery RF, Reischel U, Lebowitz J, Moore T. A randomized, clinical trial comparing the efficacy of continuous nebulized albuterol (15 mg) versus continuous nebulized albuterol (15 mg) plus ipratropium bromide (2 mg) for the treatment of acute asthma. J Emerg Med 2006;31(4):371-376.
14. Rodrigo GJ, Rodrigo C. First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropiumbromide plus albuterol in the emergency department. Am J Respir CritCare Med 2000;161(6):1862-1868.
15. Anderson M, Svartengren M, Bylin G, Philipson K, Camner P. Deposition in asthmatics of particles inhaled in air or in heliumoxygen. Am Rev Respir Dis 1993;147(3):524-528.
16. Svartengren M, Anderson M, Philipson K, Camner P. Human lung deposition of particles suspended in air or in helium/oxygen mixture. Exp Lung Res 1989;15(4):575-585.
17. Darquenne C, Prisk GK. Aerosol deposition in the human respiratory tract breathing air and 80:20 heliox. J Aerosol Med 2004;17(3):278-285.
18. Piva JP, Menna Barreto SS, Zelmanovitz F, Amantea S, Cox P. Heliox versus oxygen for nebulized aerosol therapy in children with lower airway obstruction. Pediatr Crit Care Med 2002;3(1):6-10.
19. Hess DR, Fink JB, Venkataraman ST, Kim IK, Myers TR, Tano BD. The history and physics of heliox. Respir Care 2006;51(6):608-612.
20. Kim IK, Saville AL, Sikes KL, Corcoran TE. Heliox-driven albuterol nebulization for asthma exacerbations: an overview. Respir Care 2006;51(6):613-618.
21. Hess DR, Acosta FL, Ritz RH, Kacmarek RM, Camargo CA Jr. The effect of heliox on nebulizer function using a beta-agonist bronchodilator. Chest 1999;115(1):184-189.
22. Frazier MD, Cheifetz IR. The role of heliox in paediatric respiratory disease. Paediatr Respir Rev 2010;11(1):46-53.
23. Rodrigo GJ, Pollack CV, Rodrigo C, Rowe BH. Heliox for nonintubated acute asthma patients. Cochrane Database Syst Rev 2006; (4):CD002884.
24. Everard ML, Evans M, Milner AD. Is tapping jet nebulisers worthwhile? Arch Dis Child 1994;70(6):538-539.
25. Malone RA, Hollie MC, Glynn-Barnhart A, Nelson HS. Optimal duration of nebulized albuterol therapy. Chest 1993;104(4):1114-1118.
26. Nikander K, Agertoft L, Pedersen S. Breath-synchronized nebulization diminishes the impact of patient-device interfaces (face mask or mouthpiece) on the inhaled mass of nebulized budesonide. J Asthma 2000;37(5):451-459.
27. Restrepo RD, Dickson SK, Rau JL, Gardenhire DS. An investigation of nebulized bronchodilator delivery using a pediatric lung model of spontaneous breathing. Respir Care 2006;51(1):56-61.
28. Kishida M, Suzuki I, Kabayama H, Koshibu T, Izawa M, Takeshita Y, et al. Mouthpiece versus facemask for delivery of nebulized salbutamol in exacerbated childhood asthma. J Asthma 2002;39(4): 337-339.
29. Lowenthal D, Kattan M. Facemasks versus mouthpieces for aerosol treatment of asthmatic children. Pediatr Pulmonol 1992;14(3):192-196.
30. Smaldone GC, Berg E, Nikander K. Variation in pediatric aerosol delivery: importance of facemask. J Aerosol Med 2005;18(3):354-363.
31. Amirav I, Newhouse MT. Aerosol therapy with valved holding chambers in young children: importance of the facemask seal. Pediatrics 2001;108(2):389-394.
32. Janssens HM, Tiddens HA. Facemasks and aerosol delivery by metered-dose inhaler valved holding chamber in young children: a tight seal makes the difference. J Aerosol Med 2007;20(Suppl 1):S59-S65.
33. Everard ML, Clark AR, Milner AD. Drug delivery from jet nebulisers. Arch Dis Child 1992;67(5):586-591.
34. Esposito-Festen JE, Ates B, van Vliet FJ, et al. Effect of a facemask leak on aerosol delivery from a pMDI-spacer system. J Aerosol Med 2004;17(1):1-6.
35. Everard ML, Clark AR, Milner AD. Drug delivery from holding chambers with attached facemask. Arch Dis Child 1992;67(5):580-585.
36. Rubin BK. Bye-bye, blow-by Respir Care 2007;52(8):981.
37. Rubin BK. Air and soul: the science and application of aerosol therapy. Respir Care 2010;55(7):911-921.
38. Ross DL, Gabrio BJ. Advances in metered dose inhaler technology with the development of a chlorofluorocarbon-free drug delivery system. J Aerosol Med 1999;12(3):151-160.
39. Leach CL. The CFC to HFA transition and its impact on pulmonary drug development. Respir Care 2005;50(9):1201-1208.
40. Rubin BK. Pediatric aerosol therapy: new devices and new drugs. Respir Care 2011;56(9):1411-1421.
41. Brand P, Friemel I, Meyer T, Schulz H, Heyder J, Haubetainger K. Total deposition of therapeutic particles during spontaneous and controlled inhalations. J Pharm Sci 2000;89(6):724-731.
42. Mitchell JP, Coppolo DP, Nagel MW. Electrostatics and inhaled medications: influence on delivery via pressurized metered-dose inhalers and add-on devices. Respir Care 2007;52(3):283-300.
43. Pierart F, Wildhaber JH, Vrancken I, Devadason SG, Le Souef PN. Washing plastic spacers in household detergent reduces electrostatic charge and greatly improves delivery. Eur Respir J 1999;13(3):673-678.
44. Bisgaard H, Anhoj J, Klug B, Berg E. A non-electrostatic spacer for aerosol delivery. Arch Dis Child 1995;73(3):226-230.
45. Kenyon CJ, Thorsson L, Borgstrom L, Newman SP. The effects of static charge in spacer devices on glucocorticosteroid aerosol deposition in asthmatic patients. Eur Respir J 1998;11(3):606-610.
46. Newman SP, Busse WW. Evolution of dry powder inhaler design, formulation, and performance. Respir Med 2002;96(5):293-304.
47. Pederson S, Hansen OR, Fuglsang G. Influence of inspiratory flow rate on the effect of a Turbuhaler. Arch Dis Child 1990;65(3):308-310.
48. Meakin BJ, Cainey J, Woodcock PM. Effect of exposure to humidity on terbutaline delivery from turbohaler dry powder inhalation devices. Eur Respir J 1993;6(5):760-761.